CareSuper
CareSuper - MySuper
To 30 June 2026, CareSuper - MySuper returned 7.32% a year over 10 years to a member with $50,000, after fees and taxes, against a median of 8.03% across MySuper products: 34th highest of 45. It charged $470 a year in total fees on a $50,000 balance (median $410), 38th lowest of 50, and passed APRA's 2026 performance test.
To 30 June 2026, for a $50,000 member. MySuper median 8.03%.
- Fees on $50,000
- $470median $410
- Members' accounts
- 570,070
- Assets
- $46.4 billion
- Growth assets
- 72%
Returns a year, against the MySuper median
After fees and tax, for a $50,000 member, to 30 June 2026.
- 3 years7.72%9.93%
- 5 years5.88%6.90%
- 7 years6.53%7.42%
- 10 years7.32%8.03%
Fees at each balance, against the median
Total fees and costs a year, as a share of the balance and in dollars.
- $10,0001.48% $1481.23% $123
- $25,0001.07% $2680.91% $228
- $50,0000.94% $4700.82% $410
- $100,0000.87% $8700.77% $770
- $250,0000.83% $2,0750.75% $1,875
What a $50,000 member earned, after fees and tax
| A year over | This product | MySuper median | Difference | Against its benchmark |
|---|---|---|---|---|
| 3 years | 7.72% | 9.93% | down 2.21 | down 0.74 |
| 5 years | 5.88% | 6.90% | down 1.02 | up 0.30 |
| 7 years | 6.53% | 7.42% | down 0.89 | up 0.33 |
| 10 years | 7.32% | 8.03% | down 0.71 | up 0.44 |
Differences are in percentage points a year. "Against its benchmark" compares the return before administration fees with APRA's benchmark portfolio built from this product's own mix of assets: above zero means its investment choices added value.
What it charges at five balances
| Balance | Administration | Total fees and costs | MySuper median total |
|---|---|---|---|
| $10,000 | $840.84% | $1481.48% | $123 |
| $25,000 | $1080.43% | $2681.07% | $228 |
| $50,000 | $1500.30% | $4700.94% | $410 |
| $100,000 | $2300.23% | $8700.87% | $770 |
| $250,000 | $4750.19% | $2,0750.83% | $1,875 |
A year, as APRA calculated them for 2026. Total fees and costs add investment and transaction costs to administration; insurance premiums are not included.
CareSuper - MySuper passed in 2026 and 2024
- 2026Passed
- 2024Passed
Its 2026 test measure, among all 49 MySuper products measured
The further right, the more a product beat the benchmark built from its own investments. Hover or tap a dot for its name.
Met APRA's benchmark. Its 2026 test measure was +0.38% a year over 10 years: its return against APRA's benchmark, adjusted for how its administration fees compare. -0.50% or lower fails.
Earlier years match on fund and product name, so a product that has been renamed shows no earlier result. Every 2026 result.
About this product
- Fund
- CareSuper
- Trustee
- CareSuper Pty Ltd
- Type
- Generic MySuper
- Offer
- Public offer
- APRA's product name
- CareSuper - MySuper
APRA does not publish fund websites or disclosure documents. Your annual statement and the fund's product disclosure statement have the full fee and insurance details.
Questions about CareSuper - MySuper
- Did CareSuper - MySuper pass the 2026 performance test?
- CareSuper - MySuper passed APRA's 2026 performance test, with a test measure of +0.38% a year against a fail line of -0.50%. Earlier results: 2024 passed.
- What are CareSuper - MySuper's fees?
- APRA's 2026 figures put its total fees and costs at $148 a year on $10,000, $268 a year on $25,000, $470 a year on $50,000, $870 a year on $100,000 and $2,075 a year on $250,000. Administration fees are $150 of the $470 on $50,000. Insurance premiums are extra.
- What has CareSuper - MySuper returned?
- For a member with $50,000, after fees and taxes, to 30 June 2026: 7.72% a year over 3 years, 5.88% a year over 5 years, 6.53% a year over 7 years and 7.32% a year over 10 years. Past returns do not predict future ones.
Source: Australian Prudential Regulation Authority (APRA), Comprehensive Product Performance Package 2026: data to 30 June 2026, published 28 August 2026. Licensed under CC BY 4.0 and normalised by The Finance Algorithm, which shows APRA's figures as percentages and dollars a year. APRA has not reviewed or endorsed this page.
General information only, not financial advice. Past performance is not a reliable indicator of future returns. Check your fund's product disclosure statement and your annual statement before you act, and consider whether advice suits your situation.